Ad
BIOYF Quote Trading Chart Biosyent Inc
home / stock / bioyf / bioyf quote
Quote | Biosyent Inc (OTCMKTS:BIOYF)
| Last: | $7.748 |
|---|---|
| Change Percent: | -0.9% |
| Open: | $7.89 |
| Close: | $7.748 |
| High: | $7.89 |
| Low: | $7.748 |
| Volume: | 400 |
| Last Trade Date Time: | 03/21/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
BIOYF Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $7.748 | $7.89 | $7.748 | $7.89 | $7.748 | 400 | 03-21-2025 |
| $7.82 | $7.8201 | $7.82 | $7.8201 | $7.764 | 727 | 03-20-2025 |
| $7.84 | $7.84 | $7.84 | $7.84 | $7.81 | 1,371 | 03-19-2025 |
| $7.84 | $7.84 | $7.84 | $7.84 | $7.84 | 500 | 03-18-2025 |
| $7.836 | $7.836 | $7.836 | $7.836 | $7.836 | 1,315 | 03-17-2025 |
| $7.7905 | $7.6135 | $7.7905 | $7.7905 | $7.554 | 4,589 | 03-14-2025 |
| $7.54 | $7.51 | $7.54 | $7.54 | $7.38 | 2,555 | 03-13-2025 |
| $7.51 | $0 | $7.51 | $0 | $0 | 10 | 03-12-2025 |
| $7.51 | $7.45 | $7.51 | $7.51 | $7.45 | 630 | 03-11-2025 |
| $7.475 | $7.5 | $7.475 | $7.5 | $7.475 | 955 | 03-10-2025 |
| $7.6 | $0 | $7.6 | $0 | $0 | 491 | 03-07-2025 |
| $7.6 | $7.6 | $7.6 | $7.6 | $7.6 | 670 | 03-06-2025 |
| $7.52 | $0 | $7.52 | $0 | $0 | 15 | 03-05-2025 |
| $7.52 | $7.5 | $7.52 | $7.6 | $7.5 | 550 | 03-04-2025 |
| $7.75 | $7.75 | $7.75 | $7.75 | $7.75 | 555 | 03-03-2025 |
| $7.7665 | $7.77 | $7.7665 | $7.77 | $7.75 | 686 | 02-28-2025 |
| $7.71 | $7.74 | $7.71 | $7.74 | $7.71 | 350 | 02-27-2025 |
| $7.75 | $7.75 | $7.75 | $7.75 | $7.75 | 435 | 02-26-2025 |
| $7.7706 | $7.85 | $7.7706 | $7.85 | $7.7706 | 550 | 02-25-2025 |
| $7.85 | $7.848 | $7.85 | $7.88 | $7.848 | 1,562 | 02-24-2025 |
News, Short Squeeze, Breakout and More Instantly...
Biosyent Inc Company Name:
BIOYF Stock Symbol:
OTCMKTS Market:
-0.9% G/L:
$7.748 Last:
400 Volume:
$7.89 Open:
$7.748 Close:
Biosyent Inc Website:
Ad
-
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: Return on Equity for FY 2024 was 21% as com...
-
MISSISSAUGA, Ontario, March 06, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2024 on Thursday, March 13, 2025 after market hours. A pres...
-
MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on March 14, 2...